Studies & Reports
One of our core strategies at RAMP is to keep the asthma field abreast of best practices, timely opportunities, and emerging research in order to build capacity for reducing the inequitable burden of asthma. We do this by cultivating an extensive hub of asthma-related information across a wide range of topics, including asthma management and healthcare, housing, air pollution, schools, the built environment, and more.
The majority of studies and reports that you’ll see below were published by partner organizations, agencies, and research institutions. To specifically see resources created by RAMP, check out RAMP Tools & Publications.
Would you like new opportunities and resources delivered right to your inbox? Then sign up for the RAMP Digest, our e-newsletter.
-
Study Details the Development and Validation of a Machine Learning-Based Model to Predict 30-Day In-Hospital Mortality Among ICU Patients with Asthma
A study, released in August 2025 by BMC Pulmonary Medicine, discusses the development and external validation of a machine learning–based model to predict 30-day in-hospital mortality among ICU patients with asthma. Researchers used data from 4,385 patients in the Medical Information Mart for Intensive Care IV (MIMIC-IV) database to test seven algorithms. Compared with traditional…
-
Systematic Review and Meta-Analysis Examines the Risk of Long COVID in Patients with Pre-Existing Chronic Respiratory Diseases
In January 2025, BMJ Journals released the study, “Risk of long COVID in patients with pre-existing chronic respiratory diseases: a systematic review and meta-analysis,” which gathered data from 51 studies from PubMed and Embase databases. Researchers found that pre-existing asthma was associated with 41% higher odds of long COVID, while COPD was linked to 32%…
-
Retrospective Cohort Study Exploring the Rise of New-Onset Type 2 Inflammatory Diseases After COVID-19 Infection and Vaccination
A large-scale retrospective cohort study, released by The Journal of Allergy and Clinical Immunology in 2025, explored the risk of new-onset type 2 inflammatory diseases after COVID-19 infection and vaccination. Using electronic health records from more than 118 million US patients, researchers found that COVID-19 infection significantly increased the risk of new-onset asthma, allergic rhinitis,…
-
Study Investigates Air Pollution from Port Craft and Railway Locomotives’ Effects on Respiratory Health
In August 2025, the Environment International journal published a study investigating how air pollution from port craft and railway locomotives affects respiratory health in California’s vulnerable communities. Using digital inhaler sensors and advanced dispersion modeling, researchers found that a 10 µg/m³ increase in fine particulate matter (PM2.5) was linked to a 3.42% rise in daily…
-
Study Assesses Correlation Between Neighborhood Disadvantage and Asthma-Related Emergency Department Visits After Summer Break
A study, released in July 2025 by the Journal of Allergy and Clinical Immunology, examined how neighborhood disadvantage influences the back-to-school increase in asthma-related emergency department (ED) visits. Researchers analyzed health records from 2016 to 2019 across 3,053 census tracts in Texas, focusing on children ages 5–17. In low social vulnerability neighborhoods, ED visits rose…
-
Lung Association Report Details Impacts of Emissions from Industrial Facilities
The American Lung Association (ALA) released the Clean Heat, Clean Air: Health Benefits of Modern Industrial Technologies report, examining the impact of emissions from industrial facilities that manufacture everyday products like food, paper, and clothing as well as calculating the public health benefits of transitioning to clean heat technologies. The report’s analysis revealed $1.1 trillion…
-
A Secondary Analysis to Understand Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Children in Urban Environments
Jama Pediatrics published the article, “Inflammatory Pathways in Residual Asthma Exacerbations Among Mepolizumab-Treated Urban Children: A Secondary Analysis of a Randomized Clinical Trial,” where researchers found that children receiving mepolizumab had reduced type 2 (T2) inflammation while other inflammatory pathways became more prominent during exacerbations compared to the control group. These findings suggest that dampening…
-
A Randomized Clinical Trial on The Effectiveness of a Digital Asthma Self-Management Program
A study, released by JAMA Network in July 2025, investigated the effectiveness of a digital asthma self-management (DASM) program. A randomized clinical trial of 901 adults with asthma found that the DASM program significantly improved symptom control after 12 months compared to usual care. The app-based program offered tools such as tailored reminders, symptom logging,…